Non-GAAP Adjusted EBITDA (Unaudited, in thousands)

Set forth below is a presentation of the Company’s “non-GAAP Adjusted EBITDA” and the “non-GAAP Adjusted EBITDA Margin” which is non-GAAP Adjusted EBITDA as a percentage of total revenue:
             
 
Three Months Ended June 30, Year Ended June 30,
  2013     2012     2013     2012  
 
Reconciliation of net (loss) income to Non-GAAP Adjusted EBITDA:
Net (loss) Income $ (3,480 ) $ 2,205 $

(5,065
) $ 2,910
Stock-based compensation 1,231 924 4,423 2,755
Acquisition-related transaction costs - - 145 123
Depreciation and amortization 3,100 1,410 9,129 4,372
Interest (income) expense, net 2

(12
) (309 )

(54
)
(Benefit) provision for income taxes   1,395     1,327     (1,591 )   1,955  
Non-GAAP adjusted EBITDA $ 2,248   $ 5,854   $ 6,732   $ 12,061  
 
Non-GAAP adjusted EBITDA margin   6 %   16 %   5 %   10 %
 
 

Non-GAAP Adjusted Net Income (Unaudited, in thousands per share amounts)

Set forth below is a reconciliation of the Company’s “Non-GAAP Adjusted Net Income” and “Non-GAAP Adjusted Net Income per Diluted Share”:
       
 
Three Months Ended June 30, Year Ended June 30,
  2013     2012     2013     2012  
Non-GAAP adjusted net (loss) income
GAAP net (loss) income $

(3,480
) $ 2,205 $ (5,065 ) $ 2,910
 
Add: Stock-based compensation 1,231 924 4,423 2,755
Add: Acquisition-related transaction costs - - - 123
Add: Amortization of purchased intangibles   525     382     1,793     1,109  
Subtotal of tax deductible items   1,756     1,306     6,216     3,987  
Less: tax impact of tax deductible items (40% rate)  

(702
)  

(522
)  

(2,486
)  

(1,595
)
Non-GAAP adjusted net (loss) income $ (2,426 ) $ 2,989   $ (1,335 ) $ 5,302  
 
Weighted average number of shares - diluted 29,753 30,514 29,577 25,369
 
Non-GAAP adjusted net (loss) income per diluted share $

(0.08
) $ 0.10 $ (0.05 ) $ 0.21
 
 
Three Months Ended June 30, Years Ended June 30,
  2013     2012     2013     2012  
 
GAAP net (loss) income per share $ (0.12 ) $ 0.07 $ (0.17 ) $ 0.11
 
Add: Stock-based compensation 0.04 0.03 0.15 0.11
Add: Acquisition-related transaction costs - - - -
Add: Amortization of purchased intangibles   0.02     0.01     0.05     0.05  
Subtotal of tax deductible items   0.06     0.04     0.20     0.16  
Less: tax impact of tax deductible items (40% rate)   (0.02 )   (0.01 )   (0.08 )   (0.06 )
Non-GAAP adjusted net (loss) income per share - diluted $ (0.08 ) $ 0.10   $ (0.05 ) $ 0.21  
 
 

The presentation of non-GAAP adjusted net income and non-GAAP net income per share excludes, for all periods, the effect of dividends and accretion related to preferred stock converted to common in February 2012.

If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: An Incredibly Resilient Market

Greenway Medical Technologies Inc Stock Upgraded (GWAY)

Greenway Medical Technologies Inc Stock Downgraded (GWAY)

Cramer's 'Mad Money' Recap: Staying Cautious for Coming Week's Earnings

Greenway IPO Pops on Opening